The Trump administration announced Thursday that human fetal tissue derived from abortions can no longer be used in research ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces challenges in uptake and education. Multistakeholder partnerships and ...

By targeting proteins used to splice genes, UC San Diego researchers have unlocked a new approach to treating triple-negative ...

A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer ...

Mortality from the deadliest cancers has decreased among people younger than 50 over the last three decades in the U.S., with ...

Researchers at FIU are advancing a personalized approach to cancer treatment that is showing increasingly promising results ...

The American Cancer Society's annual cancer statistics report reveals that for the first time, 70% of people diagnosed with cancer in the U.S. survive past five years, marking a significant milestone ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...

Metastasis and disease progression remain the leading causes of mortality in both breast and cervical cancer. These processes ...

A molecule produced by cancer cells can shield the brain from Alzheimer’s disease in mice. For decades, researchers have ...

Could this mark a shift in how we think about cancer therapy? At least in the laboratory, evidence suggests it may be.